galcanezumab-gnlm
Drug Details
- Generic Name
- galcanezumab-gnlm
- Brand Names
- EMGALITY
- Application Number
- BLA761063
- Sponsor
- Eli Lilly and Company
- NDC Codes
- 6
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- GALCANEZUMAB
Indications and Usage
1 INDICATIONS AND USAGE EMGALITY ® is a calcitonin-gene related peptide antagonist indicated in adults for the: preventive treatment of migraine. ( 1.1 ) treatment of episodic cluster headache. ( 1.2 ) 1.1 Migraine EMGALITY is indicated for the preventive treatment of migraine in adults. 1.2 Episodic Cluster Headache EMGALITY is indicated for the treatment of episodic cluster headache in adults.